| Nome |
# |
|
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione, file e31e10d3-1065-31fb-e053-1705fe0a5b99
|
422
|
|
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato?, file e31e10d2-4a26-31fb-e053-1705fe0a5b99
|
410
|
|
Esiti di salute e performance del Servizio Sanitario Nazionale, file e31e10d4-1a29-31fb-e053-1705fe0a5b99
|
348
|
|
Harnessing digital health technologies during and after the COVID-19 pandemic: context matters, file e31e10d4-397e-31fb-e053-1705fe0a5b99
|
192
|
|
Programma nazionale HTA per dispositivi medici: quali sfide per l’implementazione?, file e31e10d2-94b9-31fb-e053-1705fe0a5b99
|
191
|
|
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci, file e31e10d3-8f97-31fb-e053-1705fe0a5b99
|
188
|
|
Dinamiche economiche e performance del settore dei dispositivi medici in Italia, file e31e10d3-e3f9-31fb-e053-1705fe0a5b99
|
177
|
|
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies, file e31e10d4-4fb9-31fb-e053-1705fe0a5b99
|
177
|
|
Gli esiti di salute del Servizio Sanitario Nazionale, file e31e10d3-94ff-31fb-e053-1705fe0a5b99
|
176
|
|
An accelerated access pathway for innovative high-risk medical devices under the new European Union Medical Devices and health technology assessment regulations? Analysis and recommendations, file 792cb41f-4106-4a1a-baa9-e90c3ed9e992
|
152
|
|
Gli esiti di salute del Servizio Sanitario Nazionale, file e31e10d3-9500-31fb-e053-1705fe0a5b99
|
152
|
|
Esiti di salute e performance del Servizio Sanitario Nazionale, file a7982d94-7008-4faf-b82c-ee0c5acb90bd
|
149
|
|
Improving the methods for the economic evaluation of medical devices, file e31e10d2-b7cf-31fb-e053-1705fe0a5b99
|
148
|
|
Distinguishing features in the assessment of mHealth apps, file e31e10d4-4dcc-31fb-e053-1705fe0a5b99
|
147
|
|
Gli esiti di salute del Servizio Sanitario Nazionale, file e31e10d3-11cb-31fb-e053-1705fe0a5b99
|
136
|
|
Lifecycle evidence requirements for high-risk implantable medical devices: a European perspective, file e31e10d4-1b28-31fb-e053-1705fe0a5b99
|
135
|
|
Feasibility of deriving health state utilities in mycosis fungoides cutaneous T‑cell lymphoma using mapping algorithms, file e31e10d4-99ed-31fb-e053-1705fe0a5b99
|
126
|
|
L'adozione dell'innovazione tecnologica da parte degli ospedali italiani: un'analisi dei fattori endogeni, file e31e10d2-2d59-31fb-e053-1705fe0a5b99
|
121
|
|
Recommendations for developing a lifecycle, multidimensional assessment framework for mobile medical apps, file e31e10d4-9bda-31fb-e053-1705fe0a5b99
|
121
|
|
Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma, file 5bd037d3-e5ab-4dc1-b458-993a8b6b7403
|
112
|
|
Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study, file e31e10d3-8fcf-31fb-e053-1705fe0a5b99
|
111
|
|
Esiti di salute e performance del Servizio Sanitario Nazionale, file e31e10d3-d7f9-31fb-e053-1705fe0a5b99
|
100
|
|
European Union regulation of health technology assessment: what is required for it to succeed?, file e31e10d4-9426-31fb-e053-1705fe0a5b99
|
93
|
|
Mobile health divide between clinicians and patients in cancer care: results from a cross-sectional international survey, file e31e10d3-a8e9-31fb-e053-1705fe0a5b99
|
85
|
|
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci, file e31e10d3-8f03-31fb-e053-1705fe0a5b99
|
74
|
|
Valutazione di Health Technology Assessment del sistema di sanificazione biologico a base di probiotici del genere Bacillus (PCHS), file c0bfb066-2b31-4cad-953d-31afab790029
|
67
|
|
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal, file e31e10d4-624f-31fb-e053-1705fe0a5b99
|
61
|
|
Venous stenting for patients with outflow obstruction and leg ulcers: cost–effectiveness and budget impact analyses, file e31e10d4-067d-31fb-e053-1705fe0a5b99
|
59
|
|
A probiotic-based sanitation system for the reduction of healthcare associated infections and antimicrobial resistances: a budget impact analysis, file e31e10d3-f8c8-31fb-e053-1705fe0a5b99
|
56
|
|
Endovascular versus surgical creation of arteriovenous fistula in hemodialysis patients: cost-effectiveness and budget impact analyses, file e31e10d3-f002-31fb-e053-1705fe0a5b99
|
53
|
|
Should health technology assessment be more patient centric? If so, how?, file e31e10d3-e23c-31fb-e053-1705fe0a5b99
|
47
|
|
How to improve efficiency in cancer care: dimensions, methods, and areas of evaluation, file cfcd3dd2-bc3b-4358-9744-b51cb7bce3bb
|
46
|
|
Transformation of cancer care during and after the COVID pandemic, a point of no return : the experience of Italy, file e31e10d4-832d-31fb-e053-1705fe0a5b99
|
46
|
|
Initiatives to improve control, resource use, and quality of life associated with chemotherapy-induced nausea and vomiting, file e31e10d4-0028-31fb-e053-1705fe0a5b99
|
45
|
|
Development features and study characteristics of mobile health apps in the management of chronic conditions: a systematic review of randomised trials, file e31e10d4-73f0-31fb-e053-1705fe0a5b99
|
45
|
|
La funzione di HTA nelle aziende sanitarie italiane: un potenziale ancora inutilizzato?, file e31e10d2-7b85-31fb-e053-1705fe0a5b99
|
40
|
|
Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: a multicentre, prospective, intervention study, file e31e10d3-5434-31fb-e053-1705fe0a5b99
|
39
|
|
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia, file e31e10d2-dbf5-31fb-e053-1705fe0a5b99
|
36
|
|
Economic Evaluation for Devices and Drugs-Same or Different?, file e31e10d2-1a49-31fb-e053-1705fe0a5b99
|
35
|
|
Clinical outcomes and quality of life associated with the use of a biosynthetic mesh for complex ventral hernia repair: analysis of the “Italian Hernia Club” registry, file e31e10d3-f46d-31fb-e053-1705fe0a5b99
|
34
|
|
Quo vadis HTA for medical devices in Central and Eastern Europe? Recommendations to address methodological challenges, file e31e10d4-4dce-31fb-e053-1705fe0a5b99
|
33
|
|
Pushing the boundaries of evaluation, diffusion, and use of medical devices in Europe: Insights from the COMED project, file 3839a7a2-7d4f-442a-98fd-dab0ff406996
|
31
|
|
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy., file e31e10d4-621d-31fb-e053-1705fe0a5b99
|
30
|
|
The impact of surgical experience in VATS lobectomy on conversion and patient quality of life: results from a comprehensive national video-assisted thoracic surgical database, file cf1c2aa7-89d9-49dd-97d7-f23332d72814
|
26
|
|
Prefazione, file e31e10d2-9f17-31fb-e053-1705fe0a5b99
|
25
|
|
What can health systems learn from COVID-19?, file e31e10d4-2be7-31fb-e053-1705fe0a5b99
|
25
|
|
Prefazione Rapporto OASI 2015, file e31e10d2-50ed-31fb-e053-1705fe0a5b99
|
24
|
|
Investigating patients’ preferences to inform drug development decisions: novel Insights from a discrete choice experiment in migraine, file e31e10d4-609d-31fb-e053-1705fe0a5b99
|
23
|
|
Time-driven activity-based costing for capturing the complexity of healthcare processes: the case of deep vein thrombosis and leg ulcers, file 59cfb2f8-f609-4e37-87a7-7eb38e70cdfc
|
21
|
|
An electronic patient-reported outcome mobile app for data collection in type a hemophilia: design and usability study, file e31e10d4-876a-31fb-e053-1705fe0a5b99
|
21
|
|
The Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer, file e31e10d3-7455-31fb-e053-1705fe0a5b99
|
18
|
|
Evaluating the ability of an artificial-intelligence cloud-based platform designed to provide information prior to locoregional therapy for breast cancer in improving patient's satisfaction with therapy: the CINDERELLA trial, file 0db60683-e082-4b22-a0bf-c22fa93ddaf9
|
14
|
|
Diffusion and use of Health Technology Assessment in policy making: what lessons for decentralised healthcare systems?, file e31e10d2-1fd3-31fb-e053-1705fe0a5b99
|
13
|
|
Economic evaluation of a bioinductive implant for the repair of rotator cuff tears compared with standard surgery in Italy, file 0a1bbac7-3274-4bf8-a57f-2200b7d2fd11
|
12
|
|
Impella versus VA-ECMO for patients with cardiogenic shock: comprehensive systematic literature review and meta-analyses, file 0a66aaee-7593-4dce-9e4f-e71da40f6e99
|
12
|
|
An economic perspective on urinary tract infection: the "costs of resignation", file e31e10d2-20d6-31fb-e053-1705fe0a5b99
|
11
|
|
Metodologia di indagine e primi risultati sul costo sociale della depressione maggiore in Italia, file e31e10d2-21f3-31fb-e053-1705fe0a5b99
|
11
|
|
The role of product life cycle in medical technology innovation, file e31e10d2-23e2-31fb-e053-1705fe0a5b99
|
11
|
|
Planning and control of medical device investments by Italian public health authorities: a means to improve the decision-making process, file e31e10d2-2bc6-31fb-e053-1705fe0a5b99
|
11
|
|
Il governo dell’innovazione tecnologica in sanità. Il caso dell’impianto di valvola aortica transcatetere: stato dell’arte delle indicazioni e della rimborsabilità nelle regioni italiane, file e31e10d2-5248-31fb-e053-1705fe0a5b99
|
9
|
|
Challenges in the assessment of medical devices: the MedtecHTA Project, file e31e10d2-9fb0-31fb-e053-1705fe0a5b99
|
9
|
|
Cost-benefit analysis in health care: the case of bariatric surgery compared with diet, file e31e10d3-d276-31fb-e053-1705fe0a5b99
|
9
|
|
Il governo dell’innovazione tecnologica in sanità. Il caso dell’impianto di valvola aortica transcatetere: stato dell’arte delle indicazioni e della rimborsabilità nelle regioni italiane, file e31e10d2-7e12-31fb-e053-1705fe0a5b99
|
8
|
|
Key reccomendations from the MedtecHTA project, file e31e10d2-a08f-31fb-e053-1705fe0a5b99
|
8
|
|
The costs of pharmacological treatment for major depression: The Italian prospective multicentre observational incidence-based study, file e31e10d2-20b1-31fb-e053-1705fe0a5b99
|
7
|
|
Does the approach to economic evaluation in health care depend on culture, values, and institutional context?, file e31e10d2-fa59-31fb-e053-1705fe0a5b99
|
7
|
|
Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder, file e31e10d2-1826-31fb-e053-1705fe0a5b99
|
6
|
|
Le tecnologie mediche nel SSN: volumi, spesa e processi di acquisto, file e31e10d2-2a70-31fb-e053-1705fe0a5b99
|
6
|
|
Prognostic Value of the Cell Cycle Progression Score in Patients with Prostate Cancer: A Systematic Review and Meta-analysis, file e31e10d2-31c7-31fb-e053-1705fe0a5b99
|
6
|
|
Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: a systematic review, file e31e10d2-5515-31fb-e053-1705fe0a5b99
|
6
|
|
Comparing drug and non-drug technologies in comparative effectiveness research, file e31e10d2-57cc-31fb-e053-1705fe0a5b99
|
6
|
|
Economic evaluation of medical devices, file e31e10d3-319d-31fb-e053-1705fe0a5b99
|
6
|
|
Measuring value in health care: a comparative analysis of value-based frameworks, file e31e10d3-cb35-31fb-e053-1705fe0a5b99
|
6
|
|
Integrating HTA principles into procurement of medical devices: the Italian national HTA programme for medical devices, file e31e10d4-002a-31fb-e053-1705fe0a5b99
|
6
|
|
L'analisi di costo sociale. Quale ruolo per il management e l'economia sanitaria?, file e31e10d2-1827-31fb-e053-1705fe0a5b99
|
5
|
|
Costing and performance in healthcare management, file e31e10d2-1f79-31fb-e053-1705fe0a5b99
|
5
|
|
What reimbursement for coronary revascularisation with drug-eluting stents, file e31e10d2-20b4-31fb-e053-1705fe0a5b99
|
5
|
|
Valutazione economica dell’uso di Gas Plasma di perossido di idrogeno nella sterilizzazione in ambito ospedaliero, file e31e10d2-21f5-31fb-e053-1705fe0a5b99
|
5
|
|
Impact of chemotherapy-induced nausea and vomiting on health-related quality of life and resource utilization: a systematic review, file e31e10d2-4e5e-31fb-e053-1705fe0a5b99
|
5
|
|
Incentivizing research into the effectiveness of medical devices, file e31e10d2-8283-31fb-e053-1705fe0a5b99
|
5
|
|
Approccio value-based e logiche di finanziamento: implicazioni per le politiche di rimborsabilità in sanità, file e31e10d4-2102-31fb-e053-1705fe0a5b99
|
5
|
|
Systematic review for the development of a core outcome set for monofocal intraocular lenses for cataract surgery, file 6515bc0e-46cf-4a2a-83ae-40ebbc5682b5
|
4
|
|
Innovazione e competitività nei sistemi industriali regolati : le imprese dei dispositivi medici, file e31e10d2-1b41-31fb-e053-1705fe0a5b99
|
4
|
|
Il costo sociale della schizofrenia. Una rassegna ragionata della bibliografia, file e31e10d2-21f4-31fb-e053-1705fe0a5b99
|
4
|
|
Implant rates of cardiac implantable electrical devices in Europe: a systematic literature review, file e31e10d2-4a96-31fb-e053-1705fe0a5b99
|
4
|
|
Comparing drug and non-drug technologies in comparative effectiveness research, file e31e10d2-57cb-31fb-e053-1705fe0a5b99
|
4
|
|
A systematic literature review of the economic implications of chemotherapy-induced diarrhea and its impact on quality of life, file e31e10d2-585f-31fb-e053-1705fe0a5b99
|
4
|
|
Influence of sanitizing methods on healthcare-associated infections onset: a multicentre, randomized, controlled pre-post interventional study., file e31e10d2-798e-31fb-e053-1705fe0a5b99
|
4
|
|
Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: a systematic review, file e31e10d2-7e16-31fb-e053-1705fe0a5b99
|
4
|
|
Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis, file e31e10d2-811a-31fb-e053-1705fe0a5b99
|
4
|
|
Healthcare resource consumption for intermittent urinary catheterisation: cost-effectiveness of hydrophilic catheters and budget impact analyses, file e31e10d2-837c-31fb-e053-1705fe0a5b99
|
4
|
|
A systematic literature review of the economic implications of chemotherapy-induced diarrhea and its impact on quality of life, file e31e10d2-8581-31fb-e053-1705fe0a5b99
|
4
|
|
Intermittent catheterisation with hydrophilic and non-hydrophilic urinary catheters: systematic literature review and meta-analyses, file e31e10d2-9f33-31fb-e053-1705fe0a5b99
|
4
|
|
The impacts of diabetes research from 31 European Countries in 2002 to 2013, file e31e10d3-36a3-31fb-e053-1705fe0a5b99
|
4
|
|
State-of-the-art of abdominal wall surgery in Italy: coding, reimbursement, hospitalisations and expenditure for surgical meshes, file e31e10d3-af03-31fb-e053-1705fe0a5b99
|
4
|
|
The rise of rules: will the new regulation of medical devices make us safer?, file e31e10d3-ff5c-31fb-e053-1705fe0a5b99
|
4
|
|
How to reduce inequity of access to cardiac rehabilitation after Surgical Aortic Valve Replacement. Recommendations for the post-COVID era from a real world, population-based study, file e31e10d4-960d-31fb-e053-1705fe0a5b99
|
4
|
|
Liste e tempi di attesa in sanità: innovazioni, soluzioni e sfide per le regioni e le aziende sanitarie in Italia, file cc1fe042-dbd9-4d6f-9efa-3693c477676e
|
3
|
|
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani, file e31e10d2-1df1-31fb-e053-1705fe0a5b99
|
3
|
|
Impatto economico dell'utilizzo di carbossimaltosio ferrico in pazienti con anemia di carenza di ferro nelle regioni italiane, file e31e10d2-4a92-31fb-e053-1705fe0a5b99
|
3
|
| Totale |
5.537 |